
Nebula Genomics
Nebula Genomics leverages blockchain technology to eliminate middlemen and empower people to own their personal genomic data.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
$4.3m | Series A | ||
Total Funding | 000k |
Related Content
Nebula Genomics operates in the personal genomics market, offering Whole Genome Sequencing (WGS) services that decode 100% of an individual's DNA. Unlike other genetic testing companies that analyze less than 0.02% of the genome, Nebula Genomics provides a comprehensive view of an individual's genetic makeup. The company serves a diverse clientele, including consumers interested in health insights, ancestry information, and academic researchers. Its business model is direct-to-consumer, generating revenue through the sale of WGS kits and subscription services for ongoing genomic data analysis and reporting. Nebula Genomics differentiates itself by focusing on privacy and security, ensuring that users have control over their genetic data. The company also offers tools for exploring genomic data, weekly updated reports, and detailed ancestry analysis, including full Y chromosome and mitochondrial DNA sequencing.
Keywords: Whole Genome Sequencing, personal genomics, DNA testing, ancestry analysis, privacy-focused, direct-to-consumer, genomic data, health insights, academic research, subscription services.